The Medical-Surgical division of 3M is facing a dilemma. Despite being leaders in their niche, sales are stagnating. A Lead User Research team has been formed to develop new products that cater to specific customer needs. However, the executive in charge is skeptical about the feasibility and potential impact of these new products. The team must decide whether to recommend the three new products or a new business strategy to Dunlop, the executive. A suitable recommendation would be to propose a new business strategy that emphasizes competitiveness, affordability, and diversification. This approach would allow for more freedom in research and continuous contact with consumers, making it easier to introduce new products like the economy line, skin doctor line, and antimicrobial armor line.